Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
460
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
643
mi
from 43215
Boston, MA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
624
mi
from 43215
Minneapolis, MN
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
353
mi
from 43215
Chapel Hill, NC
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
353
mi
from 43215
Chapel Hill, NC
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
127
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
6
mi
from 43215
Columbus, OH
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
6
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated:  8/1/2015
Investigational Site
4052
mi
from 43215
Brussels,
Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study of VX-809 to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of VX-809 in Cystic Fibrosis Subjects Homozygous for the ∆F508-CFTR Gene Mutation
Status: Enrolling
Updated: 8/1/2015
Investigational Site
4052
mi
from 43215
Brussels,
Click here to add this to my saved trials
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Status: Enrolling
Updated:  8/4/2015
Children's Hospital of The King's Daughters
422
mi
from 43215
Norfolk, VA
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Status: Enrolling
Updated: 8/4/2015
Children's Hospital of The King's Daughters
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Effect of CPAP on Postoperative Delirium
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  8/4/2015
Duke University
352
mi
from 43215
Durham, NC
Effect of CPAP on Postoperative Delirium
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 8/4/2015
Duke University
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
Denver Health Medical Centre
1162
mi
from 43215
Denver, CO
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Denver Health Medical Centre
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
Orlando Regional Medical Centre
795
mi
from 43215
Orlando, FL
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Orlando Regional Medical Centre
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
Brody School of Medicine at East Carolina University
429
mi
from 43215
Greenville, NC
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Brody School of Medicine at East Carolina University
429
mi
from 43215
Greenville, NC
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
Hospital of the University ofPennsylvania
416
mi
from 43215
Philadelphia, PA
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Hospital of the University ofPennsylvania
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
Parkland Memorial Hospital
911
mi
from 43215
Dallas, TX
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Parkland Memorial Hospital
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
University of Texas HSC
995
mi
from 43215
Houston, TX
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
University of Texas HSC
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
Texas A&M HSC College of Medicine, Scott & White Hospital
1009
mi
from 43215
Temple, TX
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Texas A&M HSC College of Medicine, Scott & White Hospital
1009
mi
from 43215
Temple, TX
Click here to add this to my saved trials
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated:  8/5/2015
Peter Lougheed Centre/Foothills Medical Centre
1670
mi
from 43215
Calgary,
The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial
The Oscillation for ARDS Treated Early (OSCILLATE) Trial
Status: Enrolling
Updated: 8/5/2015
Peter Lougheed Centre/Foothills Medical Centre
1670
mi
from 43215
Calgary,
Click here to add this to my saved trials
Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants
Respiratory Severity and Caloric Consumption on NAVA: Randomized Crossover Trial of NAVA and SIMV
Status: Enrolling
Updated:  8/5/2015
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Randomized Crossover of NAVA and Synchronized Intermittent Pressure Ventilation in Neonates and Infants
Respiratory Severity and Caloric Consumption on NAVA: Randomized Crossover Trial of NAVA and SIMV
Status: Enrolling
Updated: 8/5/2015
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
UAB Lung Health Center
492
mi
from 43215
Birmingham, AL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
UAB Lung Health Center
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Los Angeles Biomedical Institute
1980
mi
from 43215
Torrance, CA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Los Angeles Biomedical Institute
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Pulmonary Disease Specialist/PDS Research
810
mi
from 43215
Kissimmee, FL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Pulmonary Disease Specialist/PDS Research
810
mi
from 43215
Kissimmee, FL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Well Pharma Medical Research
998
mi
from 43215
Miami, FL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Well Pharma Medical Research
998
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Florida Premier Research Institute
791
mi
from 43215
Winter Park, FL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Florida Premier Research Institute
791
mi
from 43215
Winter Park, FL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Georgia Clinical Research
433
mi
from 43215
Austell, GA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Georgia Clinical Research
433
mi
from 43215
Austell, GA
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Illinios Lung Institute
349
mi
from 43215
Peoria, IL
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Illinios Lung Institute
349
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
University of Louisville, Pulmonary Division
188
mi
from 43215
Louisville, KY
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
University of Louisville, Pulmonary Division
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Univ of Nebraska Med Ctr
682
mi
from 43215
Omaha, NE
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Univ of Nebraska Med Ctr
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Temple University Hospital
416
mi
from 43215
Philadelphia, PA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Temple University Hospital
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Spartanburg Medical Research
349
mi
from 43215
Spartanburg, SC
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Spartanburg Medical Research
349
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Texas Institute of Chest and Sleep Disorders, PA
992
mi
from 43215
Houston, TX
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Texas Institute of Chest and Sleep Disorders, PA
992
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Diagnostics Research Group
1137
mi
from 43215
San Antonio, TX
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Diagnostics Research Group
1137
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Pulmonary Associates of Richmond, Inc
342
mi
from 43215
Richmond, VA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Pulmonary Associates of Richmond, Inc
342
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated:  8/6/2015
Multicare Pulmonary Specialist
2013
mi
from 43215
Tacoma, WA
Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema
A Multi-center, Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Pharmacodynamics, Efficacy and Safety of 50 mg Tetomilast Administered as Oral Tablets in Patients With Chronic Obstructive Pulmonary Disease Associated With Emphysema THIS STUDY IS CLOSED TO ENROLLMENT AND NEW SITES
Status: Enrolling
Updated: 8/6/2015
Multicare Pulmonary Specialist
2013
mi
from 43215
Tacoma, WA
Click here to add this to my saved trials
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
Status: Enrolling
Updated:  8/7/2015
University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis
Status: Enrolling
Updated: 8/7/2015
University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
BryanLGH Heart Institute
718
mi
from 43215
Lincoln, NE
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
BryanLGH Heart Institute
718
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Ohio State University
2
mi
from 43215
Columbus, OH
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Lancaster Heart and Stroke Foundation
354
mi
from 43215
Lancaster, PA
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Lancaster Heart and Stroke Foundation
354
mi
from 43215
Lancaster, PA
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
St. Thomas Heart
332
mi
from 43215
Nashville, TN
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
St. Thomas Heart
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Sentara Cardiovascular Research Institute
422
mi
from 43215
Norfolk, VA
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Sentara Cardiovascular Research Institute
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Heart and Diabetes Center
4178
mi
from 43215
Bad Oeynhausen,
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Heart and Diabetes Center
4178
mi
from 43215
Bad Oeynhausen,
Click here to add this to my saved trials